13F Data
13F filer · CIK 1479355

VHCP Management, LLC

NEW YORK, NY · filing since Q2 2013 · last filing Feb 13, 2017
Reported value
$93.0M
$-8.7M vs prior
Positions
21
New / sold out
1 / 4
Added / reduced
2 / 0
Turnover
4.7%
buys $4.6M · sells $5.4M
Top-10 weight
87.3%

Biggest buys vs Q3 2016

ChangeSecurityShares changeChange %Est. trade value
NewRa Pharmaceuticals+232,500–+$3.5M
AddedBioCryst Pharmaceuticals Inc+150,000+14.9%+$949.5K
AddedOcera Therapeutics+55,500+6.5%+$116.5K

Biggest sells vs Q3 2016

ChangeSecurityShares changeChange %Est. trade value
Sold outZafgen Inc-602,114-100.0%$-2.0M
Sold outBeiGene Ltd-51,000-100.0%$-1.6M
Sold outAchillion Pharmaceuticals Inc-180,000-100.0%$-1.5M
Sold outREGENXBIO Inc-24,089-100.0%$-337.0K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $134.7MQ3 2013: $181.1MQ4 2013: $185.8MQ1 2014: $192.4MQ2 2014: $187.1MQ3 2014: $222.5MQ4 2014: $363.5MQ1 2015: $434.3MQ2 2015: $354.5MQ3 2015: $390.1MQ4 2015: $165.5MQ1 2016: $115.2MQ2 2016: $96.5MQ3 2016: $101.7MQ4 2016: $93.0M
Q2 2013Q4 2016

Holdings · Q4 2016

#SecuritySharesValueWeight
1DBV TechnologiesCOM456,893$31.1M33.47%
2Heron Therapeutics IncCOM1,095,734$14.4M15.43%
3Coherus Biosciences IncCOM305,505$8.6M9.25%
4BioCryst Pharmaceuticals IncCOM1,155,104$7.3M7.86%
5Avadel PharmaceuticalsCOM500,000$5.2M5.59%
6Ra PharmaceuticalsCOM232,500$3.5M3.80%
7Adverum BiotechnologiesCOM1,102,735$3.2M3.44%
8Lipocine IncCOM849,921$3.1M3.36%
9CoLucid PharmaceuticalsCOM68,190$2.5M2.67%
10Axovant Sciences LtdCOM184,110$2.3M2.46%
11 more rows. Subscribe for $29/month to see every row, download the data and use the API.